Added to YB: 2022-03-23
Pitch date: 2022-03-23
INDV [bullish]
Indivior PLC
-8.97%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Indivior PLC, together with its subsidiaries, develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally.
Market Cap
GBP 1.2B
Pitch Price
GBP 13.60
Price Target
N/A
Dividend
N/A
EV/EBITDA
3.72
P/E
-25.44
EV/Sales
1.01
Sector
Pharmaceuticals
Category
N/A
Show full summary:
INDIVIOR PLC INDV
A summary for this pitch has not been created yet.
Read full article (0 min)